|
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer |
|
|
|
Titel: |
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer |
Auteur: |
Coe, Faye Misra, Vivek McCabe, Yamini Adderley, Helen Woodhouse, Laura Ayub, Zaheen Wang, Xin Howell, Sacha Ekholm, Maria |
Verschenen in: |
Breast cancer research and treatment |
Paginering: |
Jaargang 191 () nr. 3 pagina's 535-543 |
Jaar: |
2021-11-29 |
Inhoud: |
|
Uitgever: |
Springer US, New York |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|